Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersThe detection, treatment, and biology of epithelial ovarian cancerGenome-wide association studies and the clinic: a focus on breast cancerImpact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal womenCancer genetic risk assessment for individuals at risk of familial breast cancerA mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressorGenome-wide association study identifies novel breast cancer susceptibility lociVariation of breast cancer risk among BRCA1/2 carriers.Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriersMeta-analysis of BRCA1 and BRCA2 penetranceCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAshkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseMechanisms of inherited cancer susceptibilityOvarian surface epithelium: family history and early events in ovarian cancerThe androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersCancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation statusRelationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersNipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation.Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineThe biological effects and clinical implications of BRCA mutations: where do we go from here?Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for PreventionPALB2: research reaching to clinical outcomes for women with breast cancerPancreatic Cancer GeneticsPARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future PerspectivesGenetic causes of cancer predisposition in children and adolescentsOncological safety of prophylactic breast surgery: skin-sparing and nipple-sparing versus total mastectomyBreast cancer risk factorsThe expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discoveryGenomic approaches in breast cancer researchAnti-vascular endothelial growth factor therapy in breast cancerGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskSociety of Gynecologic Oncology recommendations for the prevention of ovarian cancerChallenging and complex decisions in the management of the BRCA mutation carrierPARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignanciesFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Roles of brca2 (fancd1) in oocyte nuclear architecture, gametogenesis, gonad tumors, and genome stability in zebrafishPARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions
P2860
Q21144874-E51C6058-6855-48CC-8164-CB9D8DA6130FQ21198791-CA6D78FD-EDF9-4553-A556-6A8394F2B7BDQ22064616-19B92088-7AD5-468A-8E39-8EA096C286FCQ24195062-FD7B2DC6-8912-44D3-828E-E0FAD4F3CD3EQ24203650-58FEB9A9-BE3C-440C-A7EA-A918DDED8F5BQ24297103-EDD79DF6-1561-45E1-AE92-311A6239B1F0Q24645441-8206D386-E5D6-412E-8D24-256BA52D5BC6Q24646346-FE7EEB7A-D868-4722-BDF1-1FC161C9C697Q24654487-31A2FB08-D875-4F1A-85AB-091FEA0166B9Q24654786-F599FA5E-95CB-40F4-853B-3BB29E18058EQ24655824-F41678DE-D571-4B15-AC5B-E3D913E1FB24Q24675652-967AC72A-E18A-474E-BB9D-E6203F8B9840Q24679752-450D4AA6-814F-4E09-88D4-16000F489134Q24791495-2FC7C957-A954-40D0-A973-3D81B900CA1BQ24797305-37B655C5-441B-4802-B30E-15FC4096AAF3Q24802534-E2904AEE-DF5E-417D-9379-016A2A4684DCQ24810584-43595915-B9F5-4DF5-BDA2-CDB3F10DF6C7Q24810733-783D4525-FD43-49B7-A616-8EEE3EB5309AQ24813705-42E78830-B767-4501-B9E9-673EF3ACB2A4Q25257803-A8E2E94B-D478-4456-A4BA-0B7EBEBEBEDBQ26740273-D7CF33D2-961A-4A47-B454-DFA0B3D42D37Q26741851-EAD84BBA-4B5A-4DB4-A157-48947AE3F4D8Q26747279-AB6A3C36-B404-454C-85DC-C98E0D436EF4Q26751309-20B0C38F-C824-44AA-8DF3-68FA91A7607BQ26765235-E003A604-99A2-4A5F-9490-E45B3B9F94F1Q26768661-B65985D4-28B3-4DAF-8E72-5EF3C361ECB8Q26770339-0F335B4E-9F29-4D4C-A06E-06E65CCB3066Q26773609-9A7D3BD6-F7F3-42A4-8D84-B22282FA9C56Q26777289-E8652D72-599E-4018-AC16-5643426868B8Q26851138-AC072BCF-7D42-4568-ACB6-76A65E2274BEQ26851813-CFCDF6F0-3A04-44AA-91B1-40EDF37A6909Q26865893-6DE139B4-A097-4ACF-8DF0-DEDFD13B02B3Q26999473-15D45ADF-F7FF-41EA-9056-D32FB88F7506Q27008356-4D095E98-F014-46AE-8B8A-1F65ED2D693AQ27009306-E50E32D7-4019-42A9-B6A9-5FB640EF1545Q27026559-8680F8A6-387B-49E1-A43E-81B127854058Q27027503-7324A245-301F-4011-A568-A9320606FDF6Q27316521-7CE51EDB-BA63-4F33-97B7-CE2ED5216025Q27342643-DDD576DD-EBC0-4506-871E-84795F5CBBA0Q28071345-0EF50711-D35E-415F-BC73-67BF0B6509C5
P2860
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Average risks of breast and ov ...... ombined analysis of 22 studies
@ast
Average risks of breast and ov ...... ombined analysis of 22 studies
@en
Average risks of breast and ov ...... ombined analysis of 22 studies
@en-gb
Average risks of breast and ov ...... ombined analysis of 22 studies
@nl
type
label
Average risks of breast and ov ...... ombined analysis of 22 studies
@ast
Average risks of breast and ov ...... ombined analysis of 22 studies
@en
Average risks of breast and ov ...... ombined analysis of 22 studies
@en-gb
Average risks of breast and ov ...... ombined analysis of 22 studies
@nl
prefLabel
Average risks of breast and ov ...... ombined analysis of 22 studies
@ast
Average risks of breast and ov ...... ombined analysis of 22 studies
@en
Average risks of breast and ov ...... ombined analysis of 22 studies
@en-gb
Average risks of breast and ov ...... ombined analysis of 22 studies
@nl
P2093
P2860
P50
P3181
P356
P1476
Average risks of breast and ov ...... ombined analysis of 22 studies
@en
P2093
D M Eccles
D Thompson
P2860
P304
P3181
P356
10.1086/375033
P407
P50
P577
2003-05-01T00:00:00Z